Met (c-Met) (Tyr1003) Antibody

Catalog number:	bs-3271R Buy Now
Price:	333 €
Supplier:	Bioss Primary Conjugated Antibodies
Product name:	Met (c-Met) (Tyr1003) Antibody
Quantity:	0.1ml
Related search:	met receptor factor protooncogene hgf cancer

More details Need more?:

Long name:	Met (c-Met) (Tyr1003) Antibody
Also known as:	Met (c-Met) (Tyr1003) Antibody
Category:	Primary Antibodies
Conjugation:	Unconjugated
Target Antigen:	Met c-Met Tyr1003
Specificity:	This is a highly specific antibody against Met c-Met Tyr1003
Modification(s):	Phosphorylation
Modification site(s):	Tyr1003
Clonality:	Polyclonal antibody
Clone number:	Polyclonal antibody
Concentration:	1ug per 1ul
Source:	KLH conjugated synthetic phosphopeptide derived from human c-Met around the phosphorylation site of Tyr1003
Gene ID number:	4233
Tested Applications:	IF(IHC-P), IHC-P, WB
Recommended dilutions:	IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity:	Mouse, Rat, Human
Cross reactive species details:	not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen:	AKT, Cbl, Cells expressing c-Met include epithelial cells, Crk, ERK1 and 2, FAK, GAB1, HGF/SF stimulation of c-Met expressing cells enhances proliferation, In addition to cancer studies, JNK, Many types of cancer exhibit sustained c-Met stimulation, PI3K, PLC gamma, Ras, Shc, Signaling proteins that are phosphorylated and/or localized in response to c-Met phosphorylation include: Grb2, Src, The mature c-Met protein is a disulfide-linked heterodimer with Mr=190 kDa composed of a heavily glycosylated alpha subunit that is completely extracellular in localization, a member of the tyrosine kinase superfamily, a single transmembrane domain, also known as scatter factor (HGF/SF), and STAT3, and a beta subunit comprising an extracellular ligand binding domain, and a cytoplasmic tyrosine kinase domain, and glomerular mesenchymal cells, and protease synthesis, angiogenesis and surgical wound healing, as well as melanomas and sarcomas, blood cells of various types, breast, characteristics that are associated with invasive cell phenotype, cortactin, endothelial cells, including carcinomas of the colon, is the receptor for hepatocyte growth factor, kidney, liver, lung, migration, morphogenesis, or mutation, organ regeneration, other research areas in which c-Met is under investigation include organogenesis, ovary, overexpression, paxillin, prostate, thyroid, &euro, &trade, HGF/SF binding to c-Met stimulates receptor dimerization and the phosphorylation of numerous residues within the receptorâ, c-Met, s cytoplasmic domain
Purification method:	This antibody was purified via Protein A
Storage conditions:	50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names:	AUTS9, D249, HGF, HGF SF receptor, HGF receptor, HGF/SF receptor, HGFR, Hepatocyte growth factor receptor, Hepatocyte growth factor receptor Precursor, MET, MET_HUMAN, Met proto oncogene tyrosine kinase, Met proto-oncogene, Met proto-oncogene hepatocyte growth factor receptor, Met protooncogene, Oncogene MET, Par4, Proto-oncogene c-Met, RCCP2, Renal cell carcinoma papillary 2 gene, SF receptor, Scatter factor receptor, Tyrosine-protein kinase Met, c met, cmet, Met c-Met Tyr1003
Properties:	C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene target:	Met (c-Met) (Tyr1003)
Short name:	Met (c-Met) (Tyr1003) Antibody
Technique:	antibodies against human proteins, antibodies for, Antibody
Alternative name:	Met (c-Met) (Tyr1003) (Antibody to)
Alternative technique:	antibodies

• #met
• #receptor
• #factor
• #protooncogene
• #hgf
• #cancer